⭐⭐⭐⭐⭐ "A total no brainer"

⭐⭐⭐⭐⭐ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

Official Title: Phase 3 Study of Sacituzumab Govitecan (IMMU-132) Versus Treatment of Physician's Choice (TPC) in Subjects With Hormonal Receptor-Positive (HR+) Human Epidermal Growth Factor Receptor 2 (HER2) Negative Metastatic Breast Cancer (MBC) Who Have Failed at Least Two Prior Chemotherapy Regimens

Study ID: NCT03901339

Study Description

Brief Summary: The primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with hormonal receptor-positive (HR+) human epidermal growth factor receptor 2 (HER2-) negative metastatic breast cancer (MBC).

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

HonorHealth Research Institute, Avondale, Arizona, United States

Arizona Oncology Associates, PC, Tucson, Arizona, United States

Highlands Oncology Group, Fayetteville, Arkansas, United States

University of California, San Diego Moores Cancer Center, La Jolla, California, United States

Los Angeles Hematology Oncology Medical Group, Los Angeles, California, United States

UCLA Department of Medicine - Hematology/Oncology, Los Angeles, California, United States

University of California, Irvine Medical Center-Chao Family Comprehensive Cancer Center, Orange, California, United States

Southern California Permanente Medical Group, San Diego, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

Rocky Mountain Cancer Centers, Aurora, Colorado, United States

University of Colorado, Aurora, Colorado, United States

Yale University Cancer Center, New Haven, Connecticut, United States

Georgetown University Medical Center, Washington, District of Columbia, United States

University of Miami - Sylvester Comprehensive Cancer Center, Miami, Florida, United States

Miami Cancer Institute, Miami, Florida, United States

Orlando Health, Inc., Orlando, Florida, United States

Moffitt Cancer Center, Tampa, Florida, United States

Emory University - Winship Cancer Institute, Atlanta, Georgia, United States

Northside Hospital, Inc., Atlanta, Georgia, United States

University of Chicago Medical Center, Chicago, Illinois, United States

The University of Kansas Cancer Center, Westwood, Kansas, United States

James Graham Brown Cancer Center, Louisville, Kentucky, United States

Mercy Medical Center, Medical Oncology & Hematology, Baltimore, Maryland, United States

Maryland Oncology Hematology, P.A., Rockville, Maryland, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Dana Farber Cancer Institute, Boston, Massachusetts, United States

Allina Health, Virginia Piper Cancer Institute, Minneapolis, Minnesota, United States

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

Saint Luke's Cancer Institute, Kansas City, Missouri, United States

Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri, United States

St. Vincent Frontier Cancer Center, Billings, Montana, United States

Summit Medical Group, Florham Park, New Jersey, United States

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

New York Oncology Hematology, P.C., Albany, New York, United States

Laura and Isaac Perlmutter Cancer Center/NYU Langone Health, New York, New York, United States

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Columbia University Medical Center, New York, New York, United States

Memorial Sloan Kettering Cancer Center, New York, New York, United States

The Ohio State University, Columbus, Ohio, United States

Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States

The West Clinic, PC dba West Cancer Center, Germantown, Tennessee, United States

Tennessee Oncology, PLLC, Nashville, Tennessee, United States

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States

University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, United States

Texas Oncology-Denton South, Denton, Texas, United States

Houston Methodist Hospital/Houston Methodist Cancer Center, Houston, Texas, United States

Texas Oncology-Longview Cancer Center, Longview, Texas, United States

UT Health San Antonio - Mays Cancer Center, San Antonio, Texas, United States

Virginia Cancer Specialists, Arlington, Virginia, United States

Virginia Oncology Associates, Norfolk, Virginia, United States

Oncology & Hematology Associates of Southwest Virginia, Inc. DBA Blue Ridge Cancer Care, Salem, Virginia, United States

Northwest Medical Specialties, PLLC, Tacoma, Washington, United States

Chirec Cancer Institute, Brussels, , Belgium

Institut Jules Bordet, Brussels, , Belgium

Universitair Ziekenhuis Leuven, Leuven, , Belgium

CHU UCL Namur/Site Sainte Elisabeth, Namur, , Belgium

Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada

Centre Hospitalier de L'Universite de Montreal - HÎpital Notre-Dame, Montréal, , Canada

Centre Hospitalier Universitaire de Sherbrooke - Fleurimont, Sherbrooke, , Canada

Hopital de Mercy, Ars-Laquenexy, , France

Institut Sainte Catherine, Avignon, , France

HÎpital Jean-Minjoz, Besançon, , France

Centre Georges-Francois Leclerc, Dijon, , France

Centre Leon Berard, Lyon, , France

Institut RĂ©gional du Cancer de Montpellier, Montpellier, , France

Institut Curie, Paris, , France

Hospices Civils de Lyon, Pierre-BĂ©nite, , France

Institut de Cancérologie Lucien Neuwirth, Saint-Priest-en-Jarez, , France

Institut Claudius Regaud, Toulouse, , France

HELIOS Klinikum Berlin-Buch, Berlin, , Germany

Gynakologisches Zentrum Bonn, Bonn, , Germany

Marienhospital Bottrop, Bottrop, , Germany

StÀdtisches Klinikum Dessau, Dessau, , Germany

UniversitÀtsklinikum Erlangen, Erlangen, , Germany

Kliniken Essen-Mitte, Essen, , Germany

Centrum fĂŒr HĂ€matologie und Onkologie Bethanien, Frankfurt, , Germany

Onkologische Schwerpunktpraxis Eppendorf, Hamburg, , Germany

Gynakologisch-Onkologische Praxis Hannover, Hannover, , Germany

DIAKOVERE Krankenhaus gGmbH Henriettenstift - Standort Kirchrode, Hannover, , Germany

Nationales Centrum fĂŒr Tumorerkrankungen - Heidelberg, Heidelberg, , Germany

Praxisklinik fĂŒr HĂ€matologie und Onkologie Koblenz, Koblenz, , Germany

UniversitÀtsmedizin Mannheim, Mannheim, , Germany

Klinikum Mutterhaus der BorromÀerinnen, Trier, , Germany

Azienda Ospedaliera Spedali Civili di Brescia, Brescia, , Italy

Ospedale di Desio, Desio, , Italy

Ospedale Vito Fazzi di Lecce, Lecce, , Italy

Ospedale San Raffaele, Milano, , Italy

Azienda Ospedaliera San Gerardo di Monza, Monza, , Italy

Azienda UnitĂ  Sanitaria Locale di Piacenza-Ospedale Guglielmo da Saliceto, Piacenza, , Italy

IFO Istituto Nazionale dei Tumori Regina Elena, Rome, , Italy

Antoni van Leeuwenhoekziekenhuis, Amsterdam, , Netherlands

Medisch Centrum Haaglanden Antoniushove, Leidschendam, , Netherlands

Maastricht UMC+, Maastricht, , Netherlands

Complejo Hospitalario Universitario A Coruna, A Coruña, , Spain

Hospital QuirĂłnsalud Barcelona Instituto Oncologico Baselga, Barcelona, , Spain

Hospital Universitari Vall d'Hebron, Barcelona, , Spain

Hospital de la Santa Creu I Sant Pau, Barcelona, , Spain

Hospital Provincial de CastellĂłn, CastillĂłn, , Spain

Hospital Universitari Arnau de Vilanova, Lleida, , Spain

Hospital General Universitario Gregorio Maranon, Madrid, , Spain

Instituto Oncologico Bureau (IOB), Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Hospital Clinico Universitario de Santiago de Compostela, Santiago De Compostela, , Spain

Hospital Universitario Virgen del Rocio, Sevilla, , Spain

Royal Cornwall Hospital NHS Trust, Cornwell, , United Kingdom

Royal Surrey County Hospital, Guildford, , United Kingdom

Leicester Royal Infirmary, Leicester, , United Kingdom

Barts Health NHS Trust, London, , United Kingdom

The Royal Marsden NHS Foundation Trust, London, , United Kingdom

The Christie NHS Foundation Trust, Manchester, , United Kingdom

Contact Details

Name: Gilead Study Director

Affiliation: Gilead Sciences

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: